---
title: "Doximity (DOCS) Gets a Hold from Goldman Sachs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282103882.md"
description: "Goldman Sachs analyst David Roman has maintained a Hold rating on Doximity (DOCS) with a price target of $28.00. Roman, who covers the Healthcare sector, has an average return of -4.9% and a 37.65% success rate on his stock recommendations. Additionally, Evercore ISI's Elizabeth Anderson also issued a Hold rating on Doximity, while TipRanks – xAI reiterated a Buy rating on the stock on the same day."
datetime: "2026-04-08T20:37:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282103882.md)
  - [en](https://longbridge.com/en/news/282103882.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282103882.md)
---

# Doximity (DOCS) Gets a Hold from Goldman Sachs

Goldman Sachs analyst David Roman maintained a Hold rating on Doximity today and set a price target of $28.00.

### Easter Sale - 70% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Roman covers the Healthcare sector, focusing on stocks such as Omada Health, Inc., Boston Scientific, and Insulet. According to TipRanks, Roman has an average return of \-4.9% and a 37.65% success rate on recommended stocks.

In addition to Goldman Sachs, Doximity also received a Hold from Evercore ISI’s Elizabeth Anderson CFA in a report issued today. However, on the same day, TipRanks – xAI reiterated a Buy rating on Doximity (NYSE: DOCS).

### Related Stocks

- [HEAL.US](https://longbridge.com/en/quote/HEAL.US.md)
- [EKG.US](https://longbridge.com/en/quote/EKG.US.md)
- [DOCS.US](https://longbridge.com/en/quote/DOCS.US.md)
- [LGHT.US](https://longbridge.com/en/quote/LGHT.US.md)

## Related News & Research

- [Is It Time To Reassess Doximity (DOCS) After Its Steep Share Price Slide](https://longbridge.com/en/news/284058038.md)
- [Is It Time To Revisit Doximity (DOCS) After Its Recent Share Price Rebound](https://longbridge.com/en/news/283155835.md)
- [US Justice Department intervenes in xAI challenge to Colorado tech law](https://longbridge.com/en/news/284034361.md)
- [Insider Selling: Doximity (NYSE:DOCS) Insider Sells 2,427 Shares of Stock](https://longbridge.com/en/news/282751809.md)
- [H.C. Wainwright Reaffirms Their Buy Rating on GH Research (GHRS)](https://longbridge.com/en/news/284425229.md)